Literature DB >> 16699815

The effect of gender in diagnosing early schizophrenia--an experimental case simulation study.

Anne Høye1, Grigory Rezvy, Vidje Hansen, Reidun Olstad.   

Abstract

BACKGROUND: Studies of diagnostic practice confirm that there is a diagnostic delay in diagnosing women with schizophrenia compared to diagnosing men. The aim of the present study was to investigate the diagnostic practice of Norwegian and Russian psychiatrists when it comes to early psychosis, emphasising gender differences. We wanted to study the association between patient gender as such and diagnostic decision-making among psychiatrists.
MATERIALS AND METHODS: Psychiatrists in Norway and the Archangels region in Russia were invited to participate in a study of diagnostic practice, and received a written case description of a patient with early psychosis symptoms that could be interpreted as schizophrenia. They were, however, not informed that 50% of them received a female case description and 50% a male case description. Apart from the patient being described as "he" or "she" the stories were identical. Effects of patient gender, clinician gender, age and main area of interest were estimated using logistic regression analysis.
RESULTS: A total of 467 psychiatrists answered the questionnaire. We found that schizophrenia diagnosis was given significantly more often to the male case than to the female case. Our finding remained significant after adjustment for country, clinician gender, age and main area of interest, and is unlikely to be explained by known biases.
CONCLUSION: Patient gender in itself affects clinicians' diagnostic practice regarding schizophrenia, as schizophrenia diagnosis is given significantly more often to a male case description than to a female one, the descriptions being otherwise identical.

Entities:  

Mesh:

Year:  2006        PMID: 16699815     DOI: 10.1007/s00127-006-0066-y

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  23 in total

Review 1.  Toward reformulating the diagnosis of schizophrenia.

Authors:  M T Tsuang; W S Stone; S V Faraone
Journal:  Am J Psychiatry       Date:  2000-07       Impact factor: 18.112

2.  The reliability of psychiatric assessment: an analysis.

Authors:  N KREITMAN; P SAINSBURY; J MORRISSEY; J TOWERS; J SCRIVENER
Journal:  J Ment Sci       Date:  1961-09

3.  The ECLW Collaborative Study: III. Training and reliability of ICD-10 psychiatric diagnoses in the general hospital setting--an investigation of 220 consultants from 14 European countries. European Consultation Liaison Workgroup.

Authors:  U F Malt; F J Huyse; T Herzog; A Lobo; A J Rijssenbeek
Journal:  J Psychosom Res       Date:  1996-11       Impact factor: 3.006

Review 4.  Schizophrenia: recent epidemiologic issues.

Authors:  A Jablensky
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

Review 5.  Schizophrenia: diverse approaches to a complex disease.

Authors:  Akira Sawa; Solomon H Snyder
Journal:  Science       Date:  2002-04-26       Impact factor: 47.728

Review 6.  Symptoms of acute coronary syndromes: are there gender differences? A review of the literature.

Authors:  Holli A DeVon; Julie Johnson Zerwic
Journal:  Heart Lung       Date:  2002 Jul-Aug       Impact factor: 2.210

Review 7.  Genes for schizophrenia? Recent findings and their pathophysiological implications.

Authors:  Paul J Harrison; Michael J Owen
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

8.  Written simulation of patient-doctor encounters. 1. Research instrument for registration of the performance of general practitioners.

Authors:  M M Kuyvenhoven; H M Jacobs; F W Touw-Otten; J C van Es
Journal:  Fam Pract       Date:  1984-03       Impact factor: 2.267

9.  A comparison between an interview and a self-report method of insight assessment in chronic schizophrenia.

Authors:  Donald A Young; Zachariah Campbell; Konstantine K Zakzanis; Earl Weinstein
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

Review 10.  Reconsidering the classification of schizophrenia and manic depressive illness--a critical analysis and new conceptual model.

Authors:  Kalina Boteva; Jeffrey Lieberman
Journal:  World J Biol Psychiatry       Date:  2003-04       Impact factor: 4.132

View more
  7 in total

1.  Incidence of hospitalised schizophrenia in Finland since 1980: decreasing and increasing again.

Authors:  Raimo K R Salokangas; Mika Helminen; Anna-Maija Koivisto; Helena Rantanen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-20       Impact factor: 4.328

Review 2.  Single-case experimental designs: a systematic review of published research and current standards.

Authors:  Justin D Smith
Journal:  Psychol Methods       Date:  2012-07-30

3.  Gender differences in first episode psychosis.

Authors:  Anne Køster; Matilde Lajer; Anne Lindhardt; Bent Rosenbaum
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-06-20       Impact factor: 4.328

4.  Mortality in schizophrenia: clinical and serological predictors.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Jennifer Schroeder; Sunil Khushalani; Robert Yolken
Journal:  Schizophr Bull       Date:  2013-08-13       Impact factor: 9.306

5.  Gender differences in service use in a sample of people with schizophrenia and other psychoses.

Authors:  Raquel Iniesta; Susana Ochoa; Judith Usall
Journal:  Schizophr Res Treatment       Date:  2012-04-03

6.  Which factors influence psychiatric diagnosing in substance abuse treatment?

Authors:  Rolf Wynn; Anne Landheim; Ellen Hoxmark
Journal:  Int J Ment Health Syst       Date:  2013-06-06

7.  A cross-sectional study addressing the importance of work and other everyday activities for well-being among people with mental illness: does additional vulnerability matter?

Authors:  Lisa Eklund; A Birgitta Gunnarsson; Jan-Åke Jansson; Parvin Pooremamali; Mona Eklund
Journal:  BMC Psychiatry       Date:  2021-07-31       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.